(Q68291374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

metastatic breast cancer

1 reference

1 reference

29 December 2022

2

D Schmähl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

author name string

E. Petru

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3350851

29 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3350851

29 December 2022

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

http://link.springer.com/content/pdf/10.1007/BF00417834.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00417834/fulltext.html

29 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00417834

29 December 2022

1 reference

Journal of Cancer Research and Clinical Oncology

29 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

183-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer]

23 September 2019

cites work

1 reference

12 December 2020

Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors

1 reference

12 December 2020

Antimetastatic effects of razoxane in a rat osteosarcoma model

1 reference

12 December 2020

Alkyl phosphocholines: toxicity and anticancer properties

1 reference

12 December 2020

Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions

1 reference

12 December 2020

On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.

1 reference

12 December 2020

Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?

1 reference

12 December 2020

Cancer Treatment Reports

1

69

1415

MR Berger

1985

1 reference

29 December 2022

Vienna Clinical Weekly

5

98

790

E Petru

1986

1 reference

29 December 2022

Identifiers

DOI

10.1007/BF00417834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3350851%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference